Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2026)

Vivos Therapeutics (VVOS) has 6 years of Asset Utilization Ratio data on file, last reported at 0.78 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.78, down 29.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.78 (down 29.2% YoY), and the FY2025 annual result was 0.86, down 25.34% from the prior year.
• Asset Utilization Ratio advanced to 0.78 in Q1 2026 per VVOS's latest filing, from 0.69 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 1.31 in Q4 2023 and troughed at 0.54 in Q1 2022.
• A 5-year average of 0.92 and a median of 0.98 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio soared 120.75% in 2022, then slumped 30.02% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 1.0 in 2022, then soared by 31.44% to 1.31 in 2023, then decreased by 25.16% to 0.98 in 2024, then tumbled by 30.02% to 0.69 in 2025, then grew by 13.53% to 0.78 in 2026.
• Business Quant data shows VVOS's Asset Utilization Ratio at 0.78 in Q1 2026, 0.69 in Q4 2025, and 0.67 in Q3 2025.